originator adalimumabadalimumabNIUnon-infectious uveitisuveitis
…yes of 148 patients diagnosed with NIU were treated with either originator adalimumab (n=193, 74.23%) or a biosimilar (n=67, 25.77%). Median follow-u…
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: originator adalimumab ×
originator adalimumab
This drug is selected. Its supporting articles are shown below.